Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy

NCT00867438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

PROCEDURE: Sigmoidoscopy

Sponsor

Cosmo Technologies Ltd